Emerson S U, Huang Y K, McRill C, Lewis M, Shapiro M, London W T, Purcell R H
Hepatitis Virus Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Vaccine. 1992;10 Suppl 1:S36-9. doi: 10.1016/0264-410x(92)90539-v.
The ability of engineering variants of hepatitis A virus (strain HM175) to replicate in cell culture or to cause disease in marmosets was evaluated. Virus variants were encoded by chimeric genomes constructed from infectious cDNA clones of two viruses (wild type and cell-culture-adapted) which differed in their ability to grow in vitro and to cause acute hepatitis in marmosets. Transfection and infectivity assays indicated that virus growth in vitro could be enhanced by subcloning the cell substrate prior to infection or by introducing multiple combinations of two or more mutations into the wild type genome. Various chimeric viruses induced liver enzyme elevations in marmosets, indicating that attenuation of virulence also required multiple mutations.
对甲型肝炎病毒(HM175株)工程变体在细胞培养中复制或在狨猴中引发疾病的能力进行了评估。病毒变体由嵌合基因组编码,这些嵌合基因组由两种病毒(野生型和细胞培养适应型)的感染性cDNA克隆构建而成,这两种病毒在体外生长能力和在狨猴中引发急性肝炎的能力方面存在差异。转染和感染性测定表明,在感染前对细胞底物进行亚克隆,或在野生型基因组中引入两个或更多突变的多种组合,可增强病毒在体外的生长。各种嵌合病毒在狨猴中引起肝酶升高,表明毒力减弱也需要多个突变。